Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • FALSE CLAIMS ACT—N.D. Ind.: Falsity and Provider’s knowledge of falsity in CPT code use were issues for trial
    • ADMINISTRATION OF FDC ACT—NOTICES: Fee Rate for Using a Priority Review Voucher in Fiscal Year 2025
    • ADVERTISING (FOOD, DRUG & MEDICAL DEVICES)—N.D. Ill.: Alleged unfair practice claim from presence of benzene in Differin acne products survives dismissal
    • CLINICAL RESEARCH—FDA GUIDANCE NOTICES: Conducting Clinical Trials With Decentralized Elements; Guidance for Industry, Investigators, and Other Interested Parties Availability
    • DRUGS AND BIOLOGICS—NOTICES: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice; Draft Guidance for Industry; Availability
    • ELECTRONIC HEALTH RECORDS—S.D.N.Y.: Privacy violation claim alleging unauthorized disclosure of private health information may proceed
    • EXPERT INSIGHTS—Massachusetts Board Of Pharmacy To Take A Big Step: Licensing Nonresident Pharmacies
    • FRAUD AND ABUSE—E.D.N.Y.: Exclusion of physician from federal health care programs was supported by substantial evidence
    • GENERAL HEALTH CARE NEWS: KFF looks at post-Medicaid ‘unwinding’ enrollment
    • GENERAL HEALTH CARE NEWS—D.S.C.: Products liability claims against maker of Peridox Disinfectant Cleaner may go forward
    • HEALTH CARE EMPLOYMENT ISSUES—N.D. Ill.: Court holds Illinois right of conscience act bars COVID-19 vaccine religious exemption cases
    • LAW FIRM NEWS—Noteworthy developments in the legal community
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, EXPERT INSIGHTS—Massachusetts Board Of Pharmacy To Take A Big Step: Licensing Nonresident Pharmacies, (Sep 20, 2024)

    Organizations Mentioned:Holland & Knight, LLP

    By Tayler Chambless and Ilenna Stein of Holland & Knight

    Nonresident licensing procedure will implement almost decade old statute requirement.

    In a move that could reshape the regulatory landscape for pharmacies servicing Massachusetts residents, the Massachusetts Board of Pharmacy has announced that it wil ...

    By Tayler Chambless and Ilenna Stein of Holland & Knight

    Nonresident licensing procedure will implement almost decade old statute requirement.

    In a move that could reshape the regulatory landscape for pharmacies servicing Massachusetts residents, the Massachusetts Board of Pharmacy has announced that it will soon begin licensing nonresident pharmacies and requiring at least one nonresident pharmacist to be licensed in Massachusetts, thereby finally establishing a procedure to implement a statute that has been on the books for almost 10 years. This decision marks a significant shift in how the Board oversees out-of-state pharmacies that ship and dispense drugs into the state. As a result, all pharmacies operating within its borders will be subject to regulatory oversight and required to adhere to the Massachusetts Board of Pharmacy standards.

    Implications for Out-of-State Pharmacies Doing Business in Massachusetts

    All states currently require out-of-state pharmacies that ship into their states to have a nonresident pharmacy license, but Massachusetts is the only state that has no mechanism for obtaining such a license. Since July 1, 2015, Massachusetts statutes (Gen. Laws ch. 112 §39J) have mandated for licensure for nonresident pharmacies, including both sterile and complex nonsterile compounding nonresident pharmacies. However, without implementing regulations, the process for securing a nonresident pharmacy license never went into effect. This will soon change as the Board is expected to adopt its draft regulations soon. On Aug. 30, 2024, the Board announced that "[t]he licensing of non-resident pharmacies will become available in the coming months" (emphasis added).

    Nonresident pharmacies seeking to do or currently doing business in Massachusetts will have to navigate a new layer of state regulatory requirements going forward, which may cause disruption to operations if they do not stay informed of the new licensure requirements, as well as increase administrative and operational costs. In addition to initial licensure, nonresident pharmacies will be subject to periodic review as part of licensure renewal. Buyers and sellers of nonresident pharmacies conducting business in Massachusetts will also have to factor the licensure process into their transaction timelines and comply with any Board of Pharmacy change of ownership requirements.

    Who Must Be Licensed?

    The new Massachusetts Board of Pharmacy licensing requirements will apply only to nonresident pharmacies:

    • nonresident drug store pharmacies (retail)

    • nonresident sterile compounding pharmacies

    • nonresident complex nonsterile compounding pharmacies

    The Board clarified in an FAQ document that it does not intend to license nonresident nondispensing pharmacies, wholesalers, distributors, third-party logistics providers or manufacturers. However, the Board already licenses nonresident 503B outsourcing facilities.

    The Licensing Process The licensing process for nonresident pharmacies is expected to involve several key steps:

    1. Application Submission. Nonresident pharmacies must submit a comprehensive application, including detailed information about the pharmacy's operations, staff qualifications and compliance with federal and state regulations.

    2. Massachusetts Designated Pharmacist-in-Charge. Each nonresident pharmacy must have at least one pharmacist licensed in Massachusetts who serves as the "Designated Pharmacist-in-Charge" (PIC) responsible for compliance with Massachusetts pharmacy laws and regulations. While some states have a similar requirement for PICs, the majority of states do not, so pharmacies should take note and start planning in advance.

    3. Inspection and Review. Nonresident pharmacies will have to submit to inspection from, and provide inspection reports to, a Board-approved inspector.

    4. Ongoing Compliance. Licensed nonresident pharmacies will be subject to periodic review for ongoing compliance as part of the licensure renewal process.

    Looking Ahead

    The Massachusetts nonresident pharmacy licensing requirements are expected to take effect in the coming months, with detailed guidelines and application procedures to be outlined soon. Until licensure becomes available, nonresident pharmacies may continue dispensing medications into Massachusetts if licensed and in good standing in the pharmacy's home state. However, in preparation for obtaining pharmacy licensure, nonresident pharmacies and their pharmacists should commence the pharmacist licensing process as soon as possible. The Board currently anticipates that pharmacist licensure approval may take 30 to 60 days, but this timeline potentially could be extended depending on the volume of applications the Board receives. View pharmacist applications and instructions.

    The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

    Tayler Chambless and Ilenna Stein

    Holland & Knight

    10 St. James Avenue

    11th Floor

    Boston

    MA 02116United States

    Tel.: +1 617 5232700

    E-mail: [email protected]

    URL: www.hklaw.com/

    (c) Mondaq Ltd, 2024 - Tel. +44 (0)20 8544 8300 - http://www.mondaq.com

    ExpertInsights: NewsStory GeneralNews DrugNews DrugBiologicNews PrescriptionDrugNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use